Insider Cluster (3 insiders) ·Filed Jun 12, 2026

CYRX

Cryoport, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed3mo ago
Insider cluster: 2 insiders, $3.1M total
Actionable Insight • Neutral

The CFO's large sale is notable but likely part of a pre-arranged 10b5-1 plan or routine diversification. Given the strong historical positive drift after past neutral reports on CYRX, this cluster alone does not warrant a bearish stance. Monitor for any subsequent insider purchases or a material change in business fundamentals (e.g., upcoming earnings or guidance) that could validate or refute the selling signal.

DirectionNeutral
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d
CYRX ▲ +2.09% at T+60d
NEUTRAL call ✓ call won +2.09% · α vs SPY +1.09% · entry $14.83 → $15.14
Entry anchored
Jun 12, 03:59 PM ET
via exchange tick
T+1d
-0.81%
call -0.81% · α -0.21%
$14.71
settled 4mo ago
T+5d
-0.40%
call -0.40% · α +0.98%
$14.77
settled 3mo ago
T+20d
+5.93%
call +5.93% · α +6.68%
$15.71
settled 3mo ago
T+60d
+2.09%
call +2.09% · α +1.09%
$15.14
settled 23d ago

Price Chart

Loading chart...

Executive Summary

Two CYRX insiders (CFO and a Director) sold a combined ~$3.12M in open-market shares over a 7-day window, representing ~0.43% of the company's $725M market cap. The CFO's $2.76M sale is the dominant transaction and, while material in absolute terms, falls within the modest-to-noteworthy proportionality band. The cluster is a sell-only event with no offsetting insider purchases, but the sales appear to be part of a regular pattern (likely 10b5-1 or vesting-related), reducing their informational value. The historical calibration shows past neutral reports on CYRX have been followed by strong positive returns, suggesting the market may not view insider selling as a negative signal for this stock.

Key Financial Metrics

Direction
selling
Total Value
$3.1M
Insiders
3

Key Facts

  • CFO Robert Stefanovich sold 169,400 shares at ~$16.27 for $2.76M on 2026-06-04
  • Director Ramkumar Mandalam sold 23,214 shares at ~$15.44 for $358K on 2026-06-08
  • Total open-market sales: ~$3.12M, or ~0.43% of $725M market cap
  • No insider purchases in the cluster window
  • Past CYRX reports (all neutral) have been followed by +29% avg T+20 return, suggesting insider selling may not be a bearish signal here

Financial Impact

~$3.12M in insider sales, ~0.43% of market cap

insider ownershipfloat

Risk Factors

  • CFO selling a large stake could signal reduced confidence in near-term prospects
  • No insider buying to offset the selling creates a one-sided negative signal
  • If the sales are not part of a 10b5-1 plan, they may carry more informational weight

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (16 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-CYRX-1781303913757
5 reports for CYRX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CYRX — sortable, filterable
TypeNow
Aug 14, 2026
7w ago
Institutional Cluster
BULLISH ★ 5/10
$15.25 $15.96▲ +4.66%▲ +6.65%$17.43 (+14.30%)
Jun 21, 2026
14w ago
Institutional Cluster
MIXED ★ 4/10
$14.77 $16.51▲ +11.78%▲ +11.93%$17.43 (+18.01%)
Jun 12, 2026
15w ago
Insider Cluster
NEUTRAL ★ 4/10
$14.83 $15.71▲ +5.93%▲ +6.68%$17.43 (+17.53%)
Mar 16, 2026
28w ago
Insider Cluster
NEUTRAL ★ 3/10
$8.00 $9.95▲ +24.38%▲ +20.60%$17.43 (+117.88%)
Mar 16, 2026
28w ago
Insider Cluster
NEUTRAL ★ 4/10
$8.00 $9.95▲ +24.38%▲ +20.60%$17.43 (+117.88%)
Showing 5 of 5

US Market Status

Market Closed — Opens Mon (64h 16m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 12, 2026